Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer

Annals of Surgical Oncology

Volumn 17, Issue SUPPL. 3, 2010, Pages

  Olaya, Windy ^a   Wong, Jan ^a   Morgan, John W ^b,c   Truong, Caitlyn ^a   Roy Chowdhury, Sharmila ^a   Kazanjian, Kevork ^a   Lum, Sharon ^a,c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER STAGING; CONFERENCE PAPER; ETHNIC AND RACIAL GROUPS; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; SENTINEL LYMPH NODE; SOCIAL STATUS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALIFORNIA; FEMALE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 78149275555     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1248-0     Document Type: Conference Paper

References (24)

1. A Goyal RG Newcombe A Chhabra RE Mansel 2006 ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase Breast Cancer Res Treat 99 203 208 10.1007/s10549-006-9192-1 16541308
2. D Krag D Weaver T Ashikaga F Moffat VS Klimberg C Shriver, et al. 1998 The sentinel node in breast cancer-a multicenter validation study N Engl J Med. 339 941 946 1:STN:280:DyaK1cvhvVKntg%3D%3D 10.1056/NEJM199810013391401 9753708
3. DK Blanchard JH Donohue C Reynolds CS Grant 2003 Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer Arch Surg. 138 482 487 10.1001/archsurg.138.5.482 12742949 discussion 487-8
4. GH Lyman AE Giuliano MR Somerfield AB Benson 3rd DC Bodurka HJ Burstein, et al. 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol. 23 7703 7720 10.1200/JCO.2005.08.001 16157938
5. G Gill 2009 Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol. 16 266 275 10.1245/s10434-008-0229-z 19050973
6. NCCN Clinical Practice Guidelines in Oncology Breast Cancer v.2.2010. Available: http://www.nccn.org/professionals/physician-gls/PDF/breast.pdf/. Accessed 20 Apr 2010.
7. JL Malin EC Schneider AM Epstein J Adams EJ Emanuel KL Kahn 2006 Results of the National Initiative for Cancer Care Quality: how can we improve the quality of caner care in the United States? J Clin Oncol. 24 626 635 10.1200/JCO.2005.03.3365 16401682
8. Percentage of women with Stage I-IIb breast cancer that received either axillary node dissection or Sentinel Lymph Node Biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy). Available: http://www.qualityforum.org/ Measures-List.aspx#k=breast%2520cancer&e=1&st=&sd=&s=&p=1. Accessed 20 Apr 2010.
9. Breast Center Standards Manual. Available: http:// accreditedbreastcenters.org/standards/2009standardsmanual.pdf. Accessed 20 Apr 2010.
10. AY Chen MT Halpern NM Schrag A Stewart M Leitch E Ward 2008 Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005) J Natl Cancer Inst. 100 462 474 10.1093/jnci/djn057 18364506
11. K Yost C Perkins R Cohen C Morris W Wright 2001 Socioeconomic status and breast cancer incidence in California for different race/ethnic groups Cancer Causes Control. 12 703 711 1:STN:280:DC%2BD3MrhsVantw%3D%3D 10.1023/A: 1011240019516 11562110
12. PT Truong V Bernstein E Wai B Chua C Speers IA Olivotto 2002 Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer Int J Radiat Oncol Biol Phys. 54 794 803 10.1016/S0360-3016(02)03463-6 12377331
13. SB Edge JC Niland MA Bookman RL Theriault R Ottesen E Lepisto, et al. 2003 Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers J Natl Cancer Inst. 95 1514 1521 14559873
14. PG Gobbi C Broglia G Carnevale Maffe A Ruga E Molinari E Ascari 2002 Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessment Haematologica. 87 1151 1156 12414344
15. KY Bilimoria CM Balch JD Wayne DC Chang BE Palis SM Dy, et al. 2009 Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States J Clin Oncol. 27 1857 1863 10.1200/JCO.2008.18.7567 19273706
16. AM Naik K Joseph M Harris C Davis R Shapiro KL Hiotis 2003 Indigent breast cancer patients among all racial and ethnic groups present with more advance disease compared with nationally reported data Am J Surg. 186 400 403 10.1016/S0002-9610(03)00282-4 14553859
17. J Rescigno JC Zampell D Axelrod 2009 Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy Ann Surg Oncol. 16 687 696 10.1245/s10434-008-0195-5 19101768
18. California QuickFacts from the US Census Bureau. Available: http://quickfacts.census.gov/qfd/states/06000.html. Accessed 20 Apr 2010.
19. J Tan M Bagnell J Morgan JH Wong S Roy-Chowdhury SS Lum 2009 The identification and treatment of isolated tumor cells reflect disparities in the delivery of breast cancer care Am J Surg. 198 508 510 10.1016/j.amjsurg.2009.07. 001 19800457
20. W Olaya JH Wong JW Morgan S Roy-Chowdhury SS Lum 2009 Disparities in the surgical management of women with stage I breast cancer Am Surg. 75 869 872 19886124
21. MP Tan 2006 Surmounting the challenges of sentinel lymph node biopsy for breast cancer in non-tertiary centres and community-based practices ANZ J Surg. 76 306 309 10.1111/j.1445-2197.2006.03712.x 16768687
22. NM Zork IK Komenaka RE Pennington Jr MW Bowling LE Norton SE Clare, et al. 2008 The effect of dedicated breast surgeons on the short-term outcomes in breast cancer Ann Surg. 248 280 285 10.1097/SLA.0b013e3181784647 18650639
23. R Rao L Lilley V Andrews L Radford M Ulissey 2009 Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy Ann Surg Oncol. 16 1170 1175 10.1245/s10434-009-0421-9 19263171
24. LE McCahill A Privette T James J Sheehey-Jones J Ratliff D Majercik, et al. 2009 Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons Arch Surg. 144 455 462 10.1001/archsurg.2009.56 19451489 discussion 462-3